Evrofarma SA

ASE:EVROF.AT

0.955 (EUR) • At close November 16, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 21.64512.612.611.78111.78112.84312.8439.8489.8489.5579.55717.5858.79318.2349.11715.6757.83816.0148.00717.4668.7338.5848.5847.6847.6847.937.937.3917.3917.8157.8156.6386.6387.0438.1377.7586.7086.1847.1066.2525.736.2496.4195.6115.188
Cost of Revenue 16.95711.26811.2689.5839.58311.18111.1818.6128.6129.1449.14414.5337.28615.758.04112.876.42113.0836.7513.9256.9637.2857.2856.1466.1466.686.686.1026.1026.5746.5745.1875.1875.5656.6755.9395.1154.4655.1954.8084.725.3345.1284.5354.312
Gross Profit 4.6881.3321.3322.1982.1981.6621.6621.2361.2360.4130.4133.0521.5072.4841.0762.8051.4172.9311.2573.5411.7711.2991.2991.5381.5381.2511.2511.2891.2891.2411.2411.4511.4511.4781.4621.8191.5931.7191.9111.4441.010.9151.2911.0760.876
Gross Profit Ratio 0.2170.1060.1060.1870.1870.1290.1290.1250.1250.0430.0430.1740.1710.1360.1180.1790.1810.1830.1570.2030.2030.1510.1510.20.20.1580.1580.1740.1740.1590.1590.2190.2190.210.180.2340.2370.2780.2690.2310.1760.1460.2010.1920.169
Reseach & Development Expenses 00.080.08000.1790.179000.230.230000000000000000000000000000000000
General & Administrative Expenses 00.1750.1750.4490.4490.290.290.3990.3990.2030.2030.3560.3560.1940.1940.3240.3240.1470.1470.3030.3030.220.220.2430.2430.1780.1780.3090.3090.2460.2460.3690.3690.4550.1810.3470.2530.4150.2320.4530.4270.4280.4020.3960.399
Selling & Marketing Expenses 00.7980.7980.8980.8980.7750.7750.880.880.9960.9960.8090.8091.0041.0040.8020.8021.0551.0550.8420.8420.9510.9510.8130.8130.7450.7450.7180.7180.8570.8570.6750.6750.8140.8540.7530.6850.9441.1310.9950.5770.710.6240.6260.608
SG&A 0.9670.9730.9731.3471.3471.0651.0651.2781.2781.1991.1992.3291.1652.5351.1992.251.1252.5881.2032.291.1451.1711.1711.0561.0560.9230.9231.0271.0271.1031.1031.0441.0441.2721.0351.10.9381.3591.3631.4481.0041.1381.0261.0221.007
Other Expenses 000000000000000000000000000000000000000000000
Operating Expenses 0.9670.5290.5290.9860.9860.7260.7260.990.990.7020.7022.3290.9572.5350.5572.250.9422.5881.1112.291.3840.9790.9790.850.850.730.730.8480.8480.830.830.9090.9091.1420.9181.1870.8711.2751.011.1970.9771.1940.6660.8690.876
Operating Income 3.7210.7070.7071.1211.1210.8790.8790.2490.249-0.411-0.4110.7230.527-0.0510.2630.5550.4760.3430.331.2510.7630.2780.2780.6590.6590.4720.4720.4130.4130.2720.2720.5360.5360.3440.5820.8670.80.5860.7290.0480.1420.050.4970.313-0.034
Operating Income Ratio 0.1720.0560.0560.0950.0950.0680.0680.0250.025-0.043-0.0430.0410.06-0.0030.0290.0350.0610.0210.0410.0720.0870.0320.0320.0860.0860.060.060.0560.0560.0350.0350.0810.0810.0490.0720.1120.1190.0950.1030.0080.0250.0080.0770.056-0.007
Total Other Income Expenses Net -1.881-0.248-0.248-0.227-0.227-0.15-0.15-0.218-0.218-0.045-0.045-0.115-0.2010.8110.11-0.126-0.261-0.554-0.436-0.714-0.495-0.111-0.111-0.195-0.195-0.127-0.127-0.203-0.203-0.091-0.091-0.263-0.263-0.233-0.298-0.505-0.404-0.5-0.21-0.111-0.416-0.06-0.454-0.612-0.299
Income Before Tax 1.840.460.460.8940.8940.730.730.0320.032-0.456-0.4560.6080.3260.760.3730.4290.215-0.211-0.1060.5370.2690.1670.1670.4640.4640.3460.3460.210.210.1810.1810.2730.2730.1110.2840.3620.3960.0860.519-0.063-0.274-0.010.043-0.299-0.333
Income Before Tax Ratio 0.0850.0360.0360.0760.0760.0570.0570.0030.003-0.048-0.0480.0350.0370.0420.0410.0270.027-0.013-0.0130.0310.0310.0190.0190.060.060.0440.0440.0280.0280.0230.0230.0410.0410.0160.0350.0470.0590.0140.073-0.01-0.048-0.0020.007-0.053-0.064
Income Tax Expense 0.4390.0670.0670.1860.1860.0090.0090.0430.0430.0520.052-0.0080.0040.0240.0120.0910.046-0.1470.0740.3160.1580.0020.0020.1430.1430.2130.2130.0750.0750.0850.0850.1630.1630.1990.0030.2520.1780.3050.2250.0310.0130.1870.1380.020.172
Net Income 1.4010.3930.3930.7080.7080.7210.721-0.011-0.011-0.507-0.5070.660.330.7420.3610.3380.169-0.064-0.0320.2210.1110.1680.1680.3220.3220.1330.1330.1360.1360.0960.0960.110.11-0.0880.2870.110.218-0.2190.294-0.094-0.2610.177-0.095-0.319-0.161
Net Income Ratio 0.0650.0310.0310.060.060.0560.056-0.001-0.001-0.053-0.0530.0380.0380.0410.040.0220.022-0.004-0.0040.0130.0130.020.020.0420.0420.0170.0170.0180.0180.0120.0120.0170.017-0.0120.0350.0140.032-0.0350.041-0.015-0.0460.028-0.015-0.057-0.031
EPS 0.10.0290.0290.0520.0520.0530.053-0.001-0.001-0.037-0.0370.0480.0240.0540.0260.0250.012-0.005-0.0020.0160.0080.0120.0120.0240.0240.010.010.010.010.0070.0070.0080.008-0.0060.0210.0080.016-0.0160.022-0.007-0.0190.013-0.007-0.023-0.012
EPS Diluted 0.10.0290.0290.0520.0520.0530.053-0.001-0.001-0.037-0.0370.0480.0240.0540.0260.0250.012-0.005-0.0020.0160.0080.0120.0120.0240.0240.010.010.010.010.0070.0070.0080.008-0.0060.0210.0080.016-0.0160.022-0.007-0.0190.013-0.007-0.023-0.012
EBITDA 3.3821.1021.1021.5541.5541.2461.2460.6290.629-0.056-0.0561.430.8730.6640.6081.2330.8011.0880.6821.941.1010.620.621.021.020.8470.8470.8060.8060.6540.6540.9830.9830.7450.9351.3751.2520.8110.9880.7530.830.7041.1430.9610.628
EBITDA Ratio 0.1560.0870.0870.1320.1320.0970.0970.0640.064-0.006-0.0060.0810.0990.0360.0670.0790.1020.0680.0850.1110.1260.0720.0720.1330.1330.1070.1070.1090.1090.0840.0840.1480.1480.1060.1150.1770.1870.1310.1390.120.1450.1130.1780.1710.121